Founded in 1999, Chongqing Haifu Medical Technology Co., Ltd. is headquartered in Chongqing China and keeps being a world-leading manufacturer of non-invasive ultrasound therapeutic systems for both malignant and benign tumors. Her employee pool exceeds 400 persons including top-class experts in HIFU field.

Cooperating with Chongqing Medical University and its affiliated hospitals, Haifu has established an innovational operation mode integrated of manufacturing, marketing, R&D, and education. These would lead to effective treatment for fibroids and patients suffering from cancer, osteosarcoma and other kinds of tumors.

In October 2005, National Engineering Research Center of Ultrasound Medicine was set up by Haifu, playing an important role of transformation base of R&D, engineering and clinical medicine. Until now, it is still the only one National Engineering Research Center approved by National Development and Reform Commission of China in the field of digital medical device.

The Clinical Training Center, authorized by China Ministry of Health and situated in the 2ND Affiliated Hospital of Chongqing Medical University, has trained and qualified a large number of doctors for non-invasive Ultrasound Ablation from 13 countries and regions.

Furthermore, there are consistently academic relationships between Haifu and foreign organizations, such as University of Oxford (UK), European Institute of Oncology (Italy), Florence University (Italy), Bonn University (Germany), University of Hong Kong (China), etc.

Equipped with original innovation ability and independent intellectual property right, Haifu has established win-win cooperation with some multinational companies such as Siemens, Esaote and etc. Haifu and Siemens Medical Solutions have been jointly developing a MRI-guided Focused Ultrasound Tumor Therapeutic System. The primary consequences of this collaboration will be an important development in the treatment of malignant and benign tumors, such as uterine fibroids and osteosarcoma.

Moreover, from over 20 years' HIFU R&D experience, Haifu has developed a series of products including the CE marked Haifu Model JC Focused Ultrasound Tumor Therapeutic System, the CE marked Haifu Model JC200 Focused Ultrasound Tumor Therapeutic System, the Seapostar Ultrasound Therapeutic Device for Gynecological Diseases and the Seapopinna Ultrasound Therapeutic Device for Rhinitis. Haifu products have been installed in United Kingdom, Russia, Spain, Hong Kong China, Italy, Japan, Korea, Mainland of China, Romania, Saudi Arabia, Ukraine and etc.

The Haifu Model JC Focused Ultrasound Tumor Therapeutic System offers non-invasive treatment of solid tumors including primary and metastatic liver cancer, breast cancer, primary and metastatic malignant bone tumors, soft tissue sarcomas, and benign tumors such as uterine fibroids and breast fibroadenomas; Meanwhile it could be used for pain relief of patients with advanced-stage malignant tumors. The Haifu Model JC200 Focused Ultrasound Tumor Therapeutic System offers non-invasive treatment of uterine fibroids to reserve the patients' uterus and ablate the fibroids extracoporeally.